Peng Zhou

1.7k total citations
80 papers, 1.3k citations indexed

About

Peng Zhou is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Peng Zhou has authored 80 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 12 papers in Pharmacology and 12 papers in Physiology. Recurrent topics in Peng Zhou's work include Traditional Chinese Medicine Analysis (10 papers), Medicinal Plants and Bioactive Compounds (10 papers) and Inflammasome and immune disorders (9 papers). Peng Zhou is often cited by papers focused on Traditional Chinese Medicine Analysis (10 papers), Medicinal Plants and Bioactive Compounds (10 papers) and Inflammasome and immune disorders (9 papers). Peng Zhou collaborates with scholars based in China, Canada and Macao. Peng Zhou's co-authors include Jun Yu, Guan‐Hu Bao, Huang Jinling, Fang Hua, Hua Fang, Gang-Xiu Chu, Zhongwen Xie, Wei Wei, Liang Wang and Biao Cai and has published in prestigious journals such as Biochemical and Biophysical Research Communications, British Journal of Cancer and RSC Advances.

In The Last Decade

Peng Zhou

77 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Zhou China 21 606 200 165 145 108 80 1.3k
Huali Xu China 25 937 1.5× 201 1.0× 245 1.5× 116 0.8× 91 0.8× 74 1.7k
Guozhen Cui China 23 721 1.2× 217 1.1× 149 0.9× 152 1.0× 174 1.6× 85 1.5k
Weijian Bei China 21 508 0.8× 166 0.8× 169 1.0× 109 0.8× 58 0.5× 43 1.0k
Ru Zhou China 26 592 1.0× 207 1.0× 158 1.0× 192 1.3× 110 1.0× 57 1.4k
Cecilia Hsuan Day Taiwan 24 786 1.3× 167 0.8× 118 0.7× 253 1.7× 160 1.5× 75 1.7k
Jingping Ouyang China 22 733 1.2× 197 1.0× 127 0.8× 150 1.0× 78 0.7× 56 1.7k
Yue Jin China 25 881 1.5× 139 0.7× 129 0.8× 150 1.0× 132 1.2× 44 1.8k
Mohammed M.H. Al-Gayyar Egypt 32 879 1.5× 208 1.0× 188 1.1× 176 1.2× 175 1.6× 94 2.4k

Countries citing papers authored by Peng Zhou

Since Specialization
Citations

This map shows the geographic impact of Peng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Zhou more than expected).

Fields of papers citing papers by Peng Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Zhou. The network helps show where Peng Zhou may publish in the future.

Co-authorship network of co-authors of Peng Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Zhou. A scholar is included among the top collaborators of Peng Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Zhou. Peng Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Tingting, et al.. (2025). Study on the Modulation of NLRP1 by Natural Products in Neurodegenerative Diseases. Natural Product Communications. 20(3). 1 indexed citations
3.
Huang, Wei, et al.. (2024). Neuroprotective effect of chrysophanol in Alzheimer disease via modulating the Ca2+/EGFR-PLCγ pathway. Neuroscience Letters. 824. 137684–137684. 3 indexed citations
4.
Zhou, Peng. (2024). Research Progress in the Relationship Between P2X7 and Flavonoids in Cardiovascular Disease. Acta Poloniae Pharmaceutica - Drug Research. 81(1). 3–11. 1 indexed citations
5.
Zhang, Meng, Wei Huang, Luo Jing, et al.. (2023). Chrysophanol exerts a protective effect against Aβ25-35-induced Alzheimer’s disease model through regulating the ROS/TXNIP/NLRP3 pathway. Inflammopharmacology. 31(3). 1511–1527. 13 indexed citations
6.
Zhou, Peng, et al.. (2023). Phytochemicals as potential target on thioredoxin-interacting protein (TXNIP) for the treatment of cardiovascular diseases. Inflammopharmacology. 31(1). 207–220. 6 indexed citations
7.
Hua, Fang, Lingli Shi, & Peng Zhou. (2023). Study on the mechanism of Lu’an GuaPian tea in treating heart failure based on network pharmacology and molecular docking. Food and Agricultural Immunology. 34(1). 3 indexed citations
8.
Zhu, Jian, et al.. (2023). Colchicine inhibits the proliferation and promotes the apoptosis of papillary thyroid carcinoma cells likely due to the inhibitory effect on HDAC1. Biochemical and Biophysical Research Communications. 679. 129–138. 3 indexed citations
9.
Fang, Haiyan, et al.. (2023). Beneficial effects of flavonoids on cardiovascular diseases by influencing NLRP3 inflammasome. Inflammopharmacology. 31(4). 1715–1729. 16 indexed citations
10.
Fang, Hua, Peng Zhou, Guan‐Hu Bao, & Tie-Jun Ling. (2022). Flavonoids in Lu’an GuaPian tea as potential inhibitors of TMA‐lyase in acute myocardial infarction. Journal of Food Biochemistry. 46(7). e14110–e14110. 7 indexed citations
11.
Wang, Liang, Jian Chen, Juan Yao, et al.. (2022). Atractylenolide III Attenuates Apoptosis in H9c2 Cells by Inhibiting Endoplasmic Reticulum Stress through the GRP78/PERK/CHOP Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2022. 1–12. 10 indexed citations
12.
Zhao, Chunchun, et al.. (2022). The Protective Effect of Sheng Mai Yin on Diabetic Cardiomyopathy via NLRP3/Caspase-1 Pathway. Evidence-based Complementary and Alternative Medicine. 2022. 1–12. 6 indexed citations
13.
Zhou, Peng, et al.. (2022). Liquiritin Attenuates Angiotensin II-Induced Cardiomyocyte Hypertrophy via ATE1/TAK1-JNK1/2 Pathway. Evidence-based Complementary and Alternative Medicine. 2022. 1–13. 4 indexed citations
14.
Shi, Hui, Peng Zhou, Ge Gao, et al.. (2021). Astragaloside IV prevents acute myocardial infarction by inhibiting the TLR4/MyD88/NF‐κB signaling pathway. Journal of Food Biochemistry. 45(7). e13757–e13757. 66 indexed citations
15.
Hu, Guanhua, et al.. (2021). Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer’s disease: flavonoids and phenols. Inflammopharmacology. 29(5). 1317–1329. 39 indexed citations
16.
Zhou, Peng, Fang Hua, Xiang Wang, & Huang Jinling. (2020). Therapeutic potential of IKK-β inhibitors from natural phenolics for inflammation in cardiovascular diseases. Inflammopharmacology. 28(1). 19–37. 27 indexed citations
17.
Cai, Biao, et al.. (2020). Huang‐Pu‐Tong‐Qiao Formula Ameliorates Tau Phosphorylation by Inhibiting the CaM‐CaMKIV Pathway. Evidence-based Complementary and Alternative Medicine. 2020(1). 8956071–8956071. 6 indexed citations
18.
19.
Zhou, Peng, et al.. (2017). Monocarboxylate transporter 1 and the vulnerability of oligodendrocyte lineage cells to metabolic stresses. CNS Neuroscience & Therapeutics. 24(2). 126–134. 29 indexed citations
20.
Qi, Shuang, et al.. (2013). Neurobiological and pharmacological validity of curcumin in ameliorating memory performance of senescence-accelerated mice. Pharmacology Biochemistry and Behavior. 105. 76–82. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huali Xu Breakdown of academic impact, for papers by Guozhen Cui Breakdown of academic impact, for papers by Weijian Bei Breakdown of academic impact, for papers by Ru Zhou Breakdown of academic impact, for papers by Cecilia Hsuan Day Breakdown of academic impact, for papers by Jingping Ouyang Breakdown of academic impact, for papers by Yue Jin Breakdown of academic impact, for papers by Mohammed M.H. Al-Gayyar
Rankless by CCL
2026